Cyclin B1 (CCNB1), cyclin B2 (CCNB2), DNA topoisomerase II Alpha (TOP2A) and transcription factor fork head box protein M1 (FOXM1) have already been identified as new targets for the gene therapy of ARDS [8]. Here, CCNB1 is linked to acute respiratory distress syndrome.